As part of Alzheimer’s New Jersey’s well received caregiver and community education programming, we were pleased to host Caregivers Connect!, a special #GivingTuesday program to raise awareness about the impact of Alzheimer’s disease on New Jersey families. The program [View More]
Listen to Steve Adubato interview Alzheimer's New Jersey CEO Ken Zaentz about the important of helping those coping with Alzheimer's in New Jersey.
Jennifer and I were married for 58 years. If couples can say “we are having a baby,” I can say that “we had Alzheimer’s disease.” When she became ill with Alzheimer’s, her story became our story. Jennifer and I [View More]
The expectations and commitments of the holiday season combined with the responsibilities of caregiving can sometimes turn “the most wonderful time of the year” into the exact opposite. Caring for a loved one with dementia means that the holidays may [View More]
Traveling can be enjoyable for families impacted by dementia, but it can also bring challenges, especially during the busy holiday season. To ensure the safety, comfort, and enjoyment of everyone involved, planning is critical - and a good amount [View More]
My mom was such a lively and outgoing person, turning strangers into friends anywhere she went. She was like a superwoman; involved in everything her three daughters did like dance and art classes while she also worked part-time as [View More]
In his 1996 novel, The Notebook, author Nicholas Sparks describes a scene in which the main characters, Noah and Allie, learn that Allie has Alzheimer’s disease. “Alzheimer's... It is a barren disease, as empty and lifeless as a desert. It [View More]
Last week, Eli Lilly and Company announced that it has applied for U.S Food and Drug Administration (FDA) approval for its Alzheimer’s treatment, donanemab, and expects an FDA decision by the end of 2023. The data, released by Lilly, [View More]
On Thursday, July 6, Leqembi® (lecanemab – irmb), became the first beta-amyloid targeting medication for the treatment of Alzheimer’s disease to receive full approval from the U.S. Food and Drug Administration (FDA). The drug, from pharmaceutical companies Eisai and Biogen, received [View More]
Spring Gala Celebrating Connections At the Gala on April 27, Alzheimer’s New Jersey was pleased to recognize two leaders in the New Jersey fight against Alzheimer’s disease. Russell Rothman and Heather Rae Stafford were each presented with the [View More]
